In line with our findings, biglycan has been previously shown to induce breast cancer cell normalization, as indicated by the induction of acinar spheroid formation and reduced proliferation (28), to induce cell cycle arrest in pancreatic cancer cell lines (40), and to inhibit growth of bladder cancer cells (41). The gene discussed is BGN; the disease is urinary bladder cancer.